- CohenMalad, LLP
- /

- Resources
- /resources

- FDA Orders Nion Injury Warning for GLP-1 Drugs

Pharmaceutical Drug & Medical Device

## FDA Orders NAION Injury Warning for GLP-1 Drugs

11/21/2026

# FDA Orders New Eye Stroke Warning for Ozempic, Wegovy, Mounjaro and Other GLP-1 Drugs

**Drug Safety Alert | NAION Eye Injury Lawsuits**

The U.S. Food and Drug Administration (FDA) has ordered [new safety warnings](https://www.fda.gov/drugs/drug-safety-communications/fda-requires-safety-labeling-changes-glucagon-peptide-1-receptor-agonists-glp-1-ras-due-potential) for popular GLP-1 medications, including **Ozempic, Wegovy, Mounjaro and Zepbound**, due to a potential increased risk of a serious eye condition known as **non-arteritic anterior ischemic optic neuropathy (NAION)**, sometimes called an "eye stroke."

In its [November 9, 2026 Drug Safety Communication](https://www.fda.gov/drugs/drug-safety-communications/fda-requires-safety-labeling-changes-glucagon-peptide-1-receptor-agonists-glp-1-ras-due-potential), the FDA announced that manufacturers of all GLP-1 receptor agonist medications must add information about the potential increased risk of NAION to the Warnings and Precautions section of their drug labels.

The FDA's action follows growing concerns about the risk of sudden, potentially permanent vision loss among patients taking these widely prescribed diabetes and weight-loss medications.

## What Is NAION, or an Eye Stroke?

NAION occurs when blood flow to the optic nerve is reduced, potentially causing sudden, painless vision loss, usually in one eye. The condition can result in permanent damage, including blindness or significant visual impairment.

Symptoms may include sudden vision loss, blind spots, blurred or tunnel vision, and changes in color perception. Anyone experiencing these symptoms should seek immediate medical attention.

Following a review of 126 clinical trials involving more than 134,000 patients, the FDA identified a higher observed rate of NAION among GLP-1 users than among patients receiving comparison treatments. Although NAION remains rare, the agency concluded that the potential increased risk warrants additional safety warnings.

## CohenMalad, LLP Is Already Representing Clients in NAION Eye Injury Lawsuits Nationwide

**CohenMalad, LLP currently represents individuals who suffered serious eye injuries, including NAION and permanent vision loss, after taking GLP-1 medications.** These lawsuits raise concerns about whether pharmaceutical manufacturers adequately warned patients and healthcare providers about the potential risk of devastating vision injuries.

Our nationally recognized pharmaceutical drug litigation team includes experienced attorneys and paralegals who are actively handling these cases. We have established procedures for evaluating NAION claims, obtaining medical documentation and moving qualifying cases efficiently through the litigation process.

**We represent clients nationwide, regardless of which state they live in.** If you or a loved one developed NAION, suffered an eye stroke or experienced sudden vision loss after using [Ozempic, Wegovy, Mounjaro, Zepbound or another GLP-1 medication](https://cohenandmalad.com/personal-injury/ozempic-wegovy-mounjaro-lawyer), our legal team is ready to review your circumstances.

[**Contact CohenMalad, LLP**](https://cohenandmalad.com/contact-us) **for a free, confidential case evaluation.** Our attorneys are currently accepting new NAION eye injury cases from across the United States.

Learn more about our [GLP-1 drug injury lawsuits and legal team](https://cohenandmalad.com/personal-injury/ozempic-wegovy-mounjaro-lawyer), including other serious complications associated with these medications.

11/10/2026

## NAION Injury Attorneys Advocating for You

Learn your GLP-1 NAION Eye Injury Lawsuit options.

[Request a Case Review](https://cohenandmalad.com/contact-us)

(317) 636-6481

## News & Alerts

[Dangerous Infections Linked to Contaminated Olympus Endoscopes & Duodenoscopes](https://cohenandmalad.com/alerts/contaminated-olympus-scope-lawsuit)

[St. Francis Surgical Sterilization Failure May Have Affected Indianapolis Area Patients](https://cohenandmalad.com/alerts/surgical-sterilization-failure)

---

CohenMalad, LLP — [https://cohenandmalad.com/alerts/nion-injury-warning](https://cohenandmalad.com/alerts/nion-injury-warning)